Larotrectinib and entrectinib are tumor-agnostic tropomyosin receptor kinase (TRK) inhibitors that are indicated for the treatment of advanced or metastatic solid tumor cancers with neurotrophic ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Some issued 2 parts; eg.: Pt. 1, years 1938-1945, Pt. 2, years 1946-1952 (both parts issued Aug. 15, 1953). https://siris-libraries.si.edu/ipac20/ipac.jsp?&profile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results